FocusPerformancePartnership
In Portfolio

LBA - Lebronze alloys

LBA is a global leader in the Advanced materials space offering a range of specialty copper alloys with specific properties making them critical components in a variety of systems and end-markets.

LBA - Lebronze alloys
Overview

Headquartered in France, LBA offers a wide range of specialty copper alloys, each with specific properties (thermal resistance, ability to withstand frictions, conductivity, etc. ) making them critical components in a large variety of systems and end-markets – including Aerospace, Medical devices, Energy, Electronics, Luxury, etc. – for 600+ customers across the world.

Head Office

LBA is headquartered in France.

Global Sales

LBA serves a well-diversified client base (+600 active customers globally, mix of OEMs and distributors) both in terms of end-markets and geographies across nine locations with three main production sites in France and Germany.

Industrials sector2025 Entry into PortfolioFund Astorg VIII860 EMPLOYEESIndustrials sector2025 Entry into PortfolioFund Astorg VIII860 EMPLOYEESIndustrials sector2025 Entry into PortfolioFund Astorg VIII860 EMPLOYEESIndustrials sector2025 Entry into PortfolioFund Astorg VIII860 EMPLOYEES

Meet the team behind our deep
expertise and market-leading results

Lorenzo Zamboni

Partner, Co-Head Flagship & Head of Italy

Lorenzo Zamboni
Louis Jouglard

Director

Louis Jouglard
Nicolas Marien

Partner, Head of France and Benelux Flagship

Nicolas Marien
Paul Arhanchiague

Managing Director, Healthcare Flagship

Paul Arhanchiague

Recent News

Astorg completes acquisition of Microbiology business from Thermo Fisher Scientific, establishing an independent global diagnostics specialist
ViewMore
Healthcare
news
Astorg completes acquisition of Microbiology business from Thermo Fisher Scientific, establishing an independent global diagnostics specialist
Aug 12, 2026
Astorg-backed CordenPharma acquires AmbioPharm, strengthening its position as a leading global peptide development and manufacturing platform
ViewMore
Healthcare
news
Astorg-backed CordenPharma acquires AmbioPharm, strengthening its position as a leading global peptide development and manufacturing platform
Jun 4, 2026
Astorg-backed Steliau to acquire Acal BFI, strengthening its position as the leading European platform in value-added electronic solutions
ViewMore
Technology
news
Astorg-backed Steliau to acquire Acal BFI, strengthening its position as the leading European platform in value-added electronic solutions
Jun 1, 2026
Surfaces Group
ViewMore
Surfaces Group
Saverglass
ViewMore
Saverglass
Photonis
ViewMore
Photonis
Onduline
ViewMore
Onduline
Metalor
ViewMore
Metalor
Megadyne
ViewMore
Megadyne
Surfaces Group
ViewMore
Surfaces Group
Saverglass
ViewMore
Saverglass
Photonis
ViewMore
Photonis
Onduline
ViewMore
Onduline
Metalor
ViewMore
Metalor
Megadyne
ViewMore
Megadyne